Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
Matthias Wölfl, Philip D. Greenberg
Nature Protocols (2014) Vol. 9, Iss. 4, pp. 950-966
Open Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy
Ariel Isser, Natalie K. Livingston, Jonathan P. Schneck
Biomaterials (2020) Vol. 268, pp. 120584-120584
Open Access | Times Cited: 60
Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds
David Zhang, Alexander S. Cheung, David Mooney
Nature Protocols (2020) Vol. 15, Iss. 3, pp. 773-798
Closed Access | Times Cited: 59
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Christof C. Smith, Shengjie Chai, Amber R. Washington, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 10, pp. 1591-1604
Open Access | Times Cited: 55
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate
Akhilesh Pandey, Eric Stawiski, Steffen Durinck, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 53
Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues
Jean‐David Larouche, Assya Trofimov, Leslie Hesnard, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Cell surface–tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
D. S. Jones, Jonathan D. Nardozzi, Katharine L. Sackton, et al.
Science Advances (2022) Vol. 8, Iss. 17
Open Access | Times Cited: 33
Tracking the fate and origin of clinically relevant adoptively transferred CD8 + T cells in vivo
Aude G. Chapuis, Cindy Desmarais, Ryan Emerson, et al.
Science Immunology (2017) Vol. 2, Iss. 8
Open Access | Times Cited: 58
Improving the clinical impact of biomaterials in cancer immunotherapy
Joshua M. Gammon, Neil M. Dold, Christopher M. Jewell
Oncotarget (2016) Vol. 7, Iss. 13, pp. 15421-15443
Open Access | Times Cited: 57
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
Taigo Kato, Tatsuo Matsuda, Yuji Ikeda, et al.
Oncotarget (2018) Vol. 9, Iss. 13, pp. 11009-11019
Open Access | Times Cited: 53
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers
Diana Paola Granados, Anja Rodenbrock, J-P Laverdure, et al.
Leukemia (2016) Vol. 30, Iss. 6, pp. 1344-1354
Open Access | Times Cited: 52
Cellular Stress and General Pathological Processes
Eugeny Y. Gusev, Natalia V. Zotova
Current Pharmaceutical Design (2019) Vol. 25, Iss. 3, pp. 251-297
Closed Access | Times Cited: 43
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
Shannon Burke, Amy L. Shergold, Matthew J. Elder, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 6, pp. 1015-1027
Open Access | Times Cited: 43
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
Axel Ducret, Chloé Ackaert, Juliana Bessa, et al.
mAbs (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 39
The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease
Amy B. Hont, Allison B. Powell, Danielle Sohai, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2130-2152
Open Access | Times Cited: 25
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer
Remya Raja, Kiran K. Mangalaparthi, Anil K. Madugundu, et al.
Science Advances (2025) Vol. 11, Iss. 8
Closed Access
The T cell receptor landscape of childhood brain tumors
Itay Raphael, Zujian Xiong, Chaim T. Sneiderman, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 790
Closed Access
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
Michael Schmueck‐Henneresse, Bilal Omer, Thomas Shum, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 1, pp. 348-362
Open Access | Times Cited: 47
The antiviral effects of acteoside and the underlying IFN-γ-inducing action
Xun Song, Jiang He, Hong Xu, et al.
Food & Function (2016) Vol. 7, Iss. 7, pp. 3017-3030
Closed Access | Times Cited: 46
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells
Junya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3384-3396
Open Access | Times Cited: 35
Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors
Preethi B. Balakrishnan, Elizabeth E. Sweeney
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Leveraging biomaterials for enhancing T cell immunotherapy
Ziyan Liao, Wentao Zhang, Hanqi Zheng, et al.
Journal of Controlled Release (2022) Vol. 344, pp. 272-288
Closed Access | Times Cited: 19
A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity
Emily A. Hemann, Megan Knoll, Courtney Wilkins, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 9, pp. 1247-1256
Open Access | Times Cited: 12
Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway
Meiyue Lou, Masaaki Iwatsuki, Xiyu Wu, et al.
Annals of Surgical Oncology (2023) Vol. 31, Iss. 5, pp. 2983-2995
Closed Access | Times Cited: 11
Species comparison: human and minipig PBMC reactivity under the influence of immunomodulating compounds in vitro
Clara P. S. Pernold, Emil Lagumdzic, Maria Stadler, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs
Luo Siwei, Amber Notaro, Lan Lin
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Scroll to top